CN100482259C - Chinese medicine for treating cervical spondylosis - Google Patents
Chinese medicine for treating cervical spondylosis Download PDFInfo
- Publication number
- CN100482259C CN100482259C CNB2006101508492A CN200610150849A CN100482259C CN 100482259 C CN100482259 C CN 100482259C CN B2006101508492 A CNB2006101508492 A CN B2006101508492A CN 200610150849 A CN200610150849 A CN 200610150849A CN 100482259 C CN100482259 C CN 100482259C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- cervical spondylosis
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating cervical spondylopahy is prepared from 18 Chinese- medicinal materials including Chinese angelica root, Chuan-xiong rhizome, red peony root, notoginseng, etc.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of cervical spondylosis.
Background technology
The treatment of cervical spondylosis is the clinical a great problem of world medicine.Study for many years through the expert of China and foreign countries and to learn that the cervical spondylosis cause of disease is multiple exopathogenic factor, as strain, rheumatism wound etc. causes the long-term impaired disequilibrium of cervical region, nerve to get involved, and blood supply disorder has formed aseptic inflammation, causes the vicious cycle of hyperosteogeny, adhesion of tendon edema.Therefore, treatment aseptic inflammation and hyperosteogeny are only the treatment cervical spondylosis originally, cooperate the light manual massage and the external application of Chinese medicine again, its more remarkable treatment effect.Treat the drug price costliness of cervical spondylosis at present, 4 days dosage needs 70～80 yuan, and curative effect is not obvious.
Summary of the invention
The present invention is in order to solve the drug price costliness of present treatment cervical spondylosis, and the unconspicuous problem of curative effect provides the medicine of treatment cervical spondylosis.Crude drug and ratio of weight and number that the present invention treats the Chinese medicine of cervical spondylosis are: 12～20 parts of JINGANGGU, 15 parts of Radix Angelicae Sinensis, 10～18 parts of Rhizoma Chuanxiongs, 12～15 parts of Radix Paeoniae Rubra, 15～25 parts of the Radix Paeoniae Albas, 5～8 parts of Radix Notoginseng, 10～15 parts of Radix Puerariaes, 10～15 parts of Rhizoma Et Radix Notopterygiis, 15～18 parts of Radix Clematidis, 12 parts of drynaria baroniis, 15 parts of Spina Gleditsiae, 15 parts of Radix Salviae Miltiorrhizaes, 12～15 parts of Zaocys, 12～15 parts of Herba Erodiis, 12 parts of Herba Pyrolaes, 15 parts of milettia reticulatas, 8～10 parts of Eupolyphaga Seu Steleophagas, 10～12 parts on Flos Carthami.
The Chinese medicine that the present invention treats cervical spondylosis is that theoretical basis is organized medicine with treatment aseptic inflammation and hyperosteogeny.Crude drug of the present invention is all used except that Radix Notoginseng and is decocted in water for oral dose, and Radix Notoginseng is made powder with decoct clothes or described raw material of Chinese medicine was pulverized 100 mesh sieves make capsule, its instructions of taking, each 5,2 times on the one, the hot raw meat food of diet, suitable taking medicine after meal.The present invention makes just 15 yuan of the expensess for medicine of 100 of capsules, and the curative effect that the patient takes 10 days dosages is better than existing 4 days dosages needs 70～80 yuan curative effect.
The present invention also has good effect to the treatment of lumbar spondylosis and scapulohumeral periarthritis.
The present invention has the Chinese medicine ingredients avirulence, has no side effect, and cost is low, eutherapeutic advantage.
Chinese crude drug JINGANGGU of the present invention---bitter, flat, have Shu Jin and invigorate blood circulation, the wind-expelling pain-stopping effect.JINGANGGU is a monarch drug in the present invention, produces the saponin element after these liquid medicine aquatic foods of modern pharmacological research, and the plain sample effect of similar steroidal has stronger rheumatism analgesic effect, cures mainly Kaschin-Beck disease, quasi-rheumatoid arthritis.
Radix Notoginseng---sweet little hardship, temperature has the activating blood circulation to dissipate blood stasis hemostasis, the reducing swelling and alleviating pain specially good effect.Medication in the Radix Notoginseng traumatic injury muscle and joint disease.But this medicine should not be gone into decoct, should take evident in efficacyly with smalls with decoct, and through focus is equipped with Radix Puerariae, Rhizoma Et Radix Notopterygii guiding drug to the marrow, has the hyperosteogeny of elimination function.
Radix Angelicae Sinensis---sweet, hot, warm, have tonifying blood and regulating menstruation, activating blood circulation to dissipate blood stasis pain-relieving functions.
Rhizoma Chuanxiong---hot, warm, have promoting blood circulation to remove obstruction in the collateral, the silt pain relieving of dispelling, priming go into the focus function.
Radix Paeoniae Rubra---bitter, cool, have the promoting blood circulation and detumescence pain-relieving functions.
The Radix Paeoniae Alba---bitter, acid, cool, the yin fluid astringing that nourishes blood, easing the affected liver to relieve pain function, the traditional Chinese medical science is said the liver governing tendons arteries and veins.And one or both sides being arranged in cervical spondylosis, there is the inflammatory edema scleroma in muscle ligament, and is obvious by tenderness.
Radix Puerariae---sweet, hot, flat, have expelling pathogenic factors from muscles for reducing heat, holder skin ulcer granulation promoting, passing through under Radix Notoginseng, Rhizoma Et Radix Notopterygii interact reaches focus, waits function to the marrow.
Rhizoma Et Radix Notopterygii---hot, bitter, warm, have the function of inducing sweat, dispel the wind, win wet, pain relieving, the up uniqueness of priming.
Radix Clematidis---Xin Wen, bitter temperature have expelling wind and removing dampness, collateral dredging detumescence block and relieving pain unique function.
Drynaria baronii---bitter, warm, invigorating the kidney and strengthening the bones, wind-damp dispelling, promoting blood circulation and stopping pain, bone injury must medication
Spina Gleditsiae---hot, warm, have effect of activating blood circulation and reducing swelling.
Radix Salviae Miltiorrhizae---bitter, be slightly cold the silt of invigorating blood circulation, nourish blood, dispel, tissue regeneration promoting effect.
Zaocys---sweet, flat, dispelling wind and removing obstruction in the collateral, counteracting toxic substances.Have strong rheumatism, pain-relieving functions
Herba Erodii---bitter, little suffering, expelling wind and removing dampness, the function of dredge the meridian passage.
Herba Pyrolae---bitter, warm, have expelling wind and removing dampness, bone and muscle strengthening analgesic function.
Milettia reticulata---bitter, sweet, warm, have the promoting the circulation of blood of enriching blood, the function of dredge the meridian passage.
Eupolyphaga Seu Steleophaga---salty, have promoting blood circulation to remove blood stasis, the function of inducing menstruation to relieve menalgia.
Flos Carthami---hot, warm, have promoting blood circulation to remove obstruction in the collateral, the silt analgesic function of dispelling.
The specific embodiment
The specific embodiment one: originally be that the raw material of Chinese medicine of embodiment treatment cervical spondylosis is counted ratio by following components by weight parts and made: 12～20 parts of JINGANGGU, 15 parts of Radix Angelicae Sinensis, 10～18 parts of Rhizoma Chuanxiongs, 12～15 parts of Radix Paeoniae Rubra, 15～25 parts of the Radix Paeoniae Albas, 5～8 parts of Radix Notoginseng, 10～15 parts of Radix Puerariaes, 10～15 parts of Rhizoma Et Radix Notopterygiis, 15～18 parts of Radix Clematidis, 12 parts of drynaria baroniis, 15 parts of Spina Gleditsiae, 15 parts of Radix Salviae Miltiorrhizaes, 12～15 parts of Zaocys, 12～15 parts of Herba Erodiis, 12 parts of Herba Pyrolaes, 15 parts of milettia reticulatas, 8～10 parts of Eupolyphaga Seu Steleophagas, 10～12 parts on Flos Carthami.
The specific embodiment two: the difference of the present embodiment and the specific embodiment one is: the raw material of Chinese medicine of treatment cervical spondylosis is counted ratio by following components by weight parts and is made: 13～18 parts of JINGANGGU, 15 parts of Radix Angelicae Sinensis, 12～16 parts of Rhizoma Chuanxiongs, 14～14 parts of Radix Paeoniae Rubra, 17～23 parts of the Radix Paeoniae Albas, 6～7 parts of Radix Notoginseng, 11～14 parts of Radix Puerariaes, 11～14 parts of Rhizoma Et Radix Notopterygiis, 16～17 parts of Radix Clematidis, 12 parts of drynaria baroniis, 15 parts of Spina Gleditsiae, 15 parts of Radix Salviae Miltiorrhizaes, 13～14 parts of Zaocys, 13～14 parts of Herba Erodiis, 12 parts of Herba Pyrolaes, 15 parts of milettia reticulatas, 9～10 parts of Eupolyphaga Seu Steleophagas, 11～12 parts on Flos Carthami.Other is identical with embodiment one.
The specific embodiment three: the difference of the present embodiment and the specific embodiment one is: the raw material of Chinese medicine of treatment cervical spondylosis is counted ratio by following components by weight parts and is made: 16 parts of JINGANGGU, 15 parts of Radix Angelicae Sinensis, 16 parts of Rhizoma Chuanxiongs, 13 parts of Radix Paeoniae Rubra, 16 parts of the Radix Paeoniae Albas, 7 parts of Radix Notoginseng, 13 parts of Radix Puerariaes, 14 parts of Rhizoma Et Radix Notopterygiis, 16 parts of Radix Clematidis, 12 parts of drynaria baroniis, 15 parts of Spina Gleditsiae, 15 parts of Radix Salviae Miltiorrhizaes, 14 parts of Zaocys, 14 parts of Herba Erodiis, 12 parts of Herba Pyrolaes, 15 parts of milettia reticulatas, 9 parts of Eupolyphaga Seu Steleophagas, 11 parts on Flos Carthami.Other is identical with embodiment one.
The specific embodiment four: the raw material of Chinese medicine of present embodiment treatment cervical spondylosis is all made water preparation except that Radix Notoginseng powder, Radix Notoginseng is made powder and share with water preparation.Other is identical with embodiment one.
The specific embodiment five: present embodiment was pulverized 100 mesh sieves with described raw material of Chinese medicine and was made capsule.Other is identical with embodiment one.
The present invention treats the pharmacodynamic experiment summary of cervical spondylosis:
1, case selection standard: dizziness, headache, Wry Neck, sour bloated, the numb pain in back are arranged; Myasthenia of limbs, blurring of vision, tinnitus, feel sick, that cardiopalmus, the cervical region one or both sides of having had a medical check-up are pushed pain is obvious, and the scleroma pain with tenderness is arranged, all at certain side L2,3,4,5 is obvious; The most prolapse of part patient's cervical vertebra vertebra camber or be tetanic; The cervical spondylosis patient of serious company and thoracic vertebra epimere symptom is totally 100 people, wherein male 38 people, women 52 people, 17 years old of age minimum, maximum 60 years old, 38.4 years old mean age.
2, diagnostic criteria: dizziness, headache, Wry Neck, acid is expanded, the symptom of numb pain is suffered from the back cervical spondylosis patient 60 people are arranged; Myasthenia of limbs, blurring of vision, tinnitus, feel sick, that cardiopalmus, the cervical region one or both sides of having had a medical check-up are pushed pain is obvious, and the scleroma pain with tenderness arranged, all at certain side L2,3, cervical spondylosis patient 30 people of 4,5 tangible symptoms, the most prolapse of part patient's cervical vertebra vertebra camber or be cervical spondylosis patient 6 people of tetanic symptom; Cervical spondylosis patient 4 people of the symptom of serious company and thoracic vertebra epimere.
3, the contained composition of medication: 16 parts of JINGANGGU, 15 parts of Radix Angelicae Sinensis, 10～18 parts of Rhizoma Chuanxiongs, 13 parts of Radix Paeoniae Rubra, 16 parts of the Radix Paeoniae Albas, 7 parts of Radix Notoginseng, 13 parts of Radix Puerariaes, 14 parts of Rhizoma Et Radix Notopterygiis, 16 parts of Radix Clematidis, 12 parts of drynaria baroniis, 15 parts of Spina Gleditsiae, 15 parts of Radix Salviae Miltiorrhizaes, 14 parts of Zaocys, 14 parts of Herba Erodiis, 12 parts of Herba Pyrolaes, 15 parts of milettia reticulatas, 9 parts of Eupolyphaga Seu Steleophagas, 11 parts on Flos Carthami.
4, administrated method: raw material of Chinese medicine of the present invention is all used except that Radix Notoginseng and is decocted in water for oral dose, and it is each 5 with decoct clothes or capsular instructions of taking that Radix Notoginseng is made powder, 2 times on the one; 10 days one courses of treatment.The hot raw meat food of diet, suitable taking medicine after meal.
5, curative effect judging standard: pain disappears, and cervical region is pushed no pain.
Aforesaid 100 examples have dizziness, headache, Wry Neck, acid is expanded, the symptom of numb pain is suffered from the back cervical spondylosis patient, by taking 8 days cure rates 100% of capsule; Myasthenia of limbs, blurring of vision, tinnitus, feel sick, that cardiopalmus, the cervical region one or both sides of having had a medical check-up are pushed pain is obvious, and the scleroma pain with tenderness arranged, all at certain side L2,3,10 days cure rates 96% of the cervical spondylosis patient of 4,5 tangible symptoms, the most prolapse of part patient's cervical vertebra vertebra camber or be cervical spondylosis patient's two course cure rates 82% of tetanic symptom; Cervical spondylosis patient's three course cure rates 60% of the symptom of serious company and thoracic vertebra epimere, total effective rate 100%
The present invention also has good effect to the treatment of lumbar spondylosis and scapulohumeral periarthritis.
The present invention has the traditional Chinese medicine ingredients avirulence, has no side effect, and cost is low, eutherapeutic advantage.
Claims (5)
1, a kind of Chinese medicine for the treatment of cervical spondylosis, the crude drug and the ratio of weight and number that it is characterized in that this Chinese medicine are: 12～20 parts of JINGANGGU, 15 parts of Radix Angelicae Sinensis, 10～18 parts of Rhizoma Chuanxiongs, 12～15 parts of Radix Paeoniae Rubra, 15～25 parts of the Radix Paeoniae Albas, 5～8 parts of Radix Notoginseng, 10～15 parts of Radix Puerariaes, 10～15 parts of Rhizoma Et Radix Notopterygiis, 15～18 parts of Radix Clematidis, 12 parts of drynaria baroniis, 15 parts of Spina Gleditsiae, 15 parts of Radix Salviae Miltiorrhizaes, 12～15 parts of Zaocys, 12～15 parts of Herba Erodiis, 12 parts of Herba Pyrolaes, 15 parts of milettia reticulatas, 8～10 parts of Eupolyphaga Seu Steleophagas, 10～12 parts on Flos Carthami.
2, a kind of Chinese medicine for the treatment of cervical spondylosis according to claim 1 is characterized in that the crude drug of this Chinese medicine and ratio of weight and number are: 13～18 parts of JINGANGGU, 15 parts of Radix Angelicae Sinensis, 12～16 parts of Rhizoma Chuanxiongs, 14～14 parts of Radix Paeoniae Rubra, 17～23 parts of the Radix Paeoniae Albas, 6～7 parts of Radix Notoginseng, 11～14 parts of Radix Puerariaes, 11～14 parts of Rhizoma Et Radix Notopterygiis, 16～17 parts of Radix Clematidis, 12 parts of drynaria baroniis, 15 parts of Spina Gleditsiae, 15 parts of Radix Salviae Miltiorrhizaes, 13～14 parts of Zaocys, 13～14 parts of Herba Erodiis, 12 parts of Herba Pyrolaes, 15 parts of milettia reticulatas, 9～10 parts of Eupolyphaga Seu Steleophagas, 11～12 parts on Flos Carthami.
3, a kind of Chinese medicine for the treatment of cervical spondylosis according to claim 1 is characterized in that the crude drug of this Chinese medicine and ratio of weight and number are: 16 parts of JINGANGGU, 15 parts of Radix Angelicae Sinensis, 10～18 parts of Rhizoma Chuanxiongs, 13 parts of Radix Paeoniae Rubra, 16 parts of the Radix Paeoniae Albas, 7 parts of Radix Notoginseng, 13 parts of Radix Puerariaes, 14 parts of Rhizoma Et Radix Notopterygiis, 16 parts of Radix Clematidis, 12 parts of drynaria baroniis, 15 parts of Spina Gleditsiae, 15 parts of Radix Salviae Miltiorrhizaes, 14 parts of Zaocys, 14 parts of Herba Erodiis, 12 parts of Herba Pyrolaes, 15 parts of milettia reticulatas, 9 parts of Eupolyphaga Seu Steleophagas, 11 parts on Flos Carthami.
4, a kind of Chinese medicine for the treatment of cervical spondylosis according to claim 1 is characterized in that the crude drug of this Chinese medicine is all made water preparation except that Radix Notoginseng powder, and Radix Notoginseng is made powder and share with water preparation.
5, a kind of Chinese medicine for the treatment of cervical spondylosis according to claim 1 is characterized in that crude drug with described Chinese medicine pulverized 100 mesh sieves and makes capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101508492A CN100482259C (en) | 2006-09-29 | 2006-09-29 | Chinese medicine for treating cervical spondylosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101508492A CN100482259C (en) | 2006-09-29 | 2006-09-29 | Chinese medicine for treating cervical spondylosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1939492A CN1939492A (en) | 2007-04-04 |
| CN100482259C true CN100482259C (en) | 2009-04-29 |
Family
ID=37958194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006101508492A Expired - Fee Related CN100482259C (en) | 2006-09-29 | 2006-09-29 | Chinese medicine for treating cervical spondylosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100482259C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103705681B (en) * | 2014-01-14 | 2018-03-13 | 山东省千佛山医院 | A kind of Chinese herbs paste for treating cervical spondylopathy |
-
2006
- 2006-09-29 CN CNB2006101508492A patent/CN100482259C/en not_active Expired - Fee Related
Non-Patent Citations (4)
| Title |
|---|
| 中医药治疗颈椎病的临床研究进展. 曹长恩等.中医药信息，第19卷第6期. 2002 |
| 中医药治疗颈椎病的临床研究进展. 曹长恩等.中医药信息，第19卷第6期. 2002 * |
| 颈椎病的近期临床治疗概况. 段爱平等.江西中医学院学报，第11卷第2期. 1999 |
| 颈椎病的近期临床治疗概况. 段爱平等.江西中医学院学报，第11卷第2期. 1999 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1939492A (en) | 2007-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101264275B (en) | Medicated pillow for treating scapulohumeral periarthritis and cervical spondylosis | |
| CN103550685B (en) | A kind of Chinese medicine composition for the treatment of lumbago and skelalgia | |
| CN103349770B (en) | Traditional Chinese medicine composition for treating diarrhoea | |
| CN100998722B (en) | Oral traditional Chinese medicine for treating delayed menstrual ciycle menalgia | |
| CN101376016B (en) | Method for preparing Chinese medicine for treating hyperlipemia | |
| CN102335265A (en) | Chinese medicament for treating psoriasis | |
| CN103611100B (en) | A kind for the treatment of is had a toothache the Chinese medicine of disease | |
| CN1911345A (en) | Decoction for treating sharp ache type menorrhalgia, and its prepn. method | |
| CN100482259C (en) | Chinese medicine for treating cervical spondylosis | |
| CN104042698A (en) | Fire treatment liquid | |
| CN103784824A (en) | Chinese herbal preparation for treating lumbar disc herniation and rheumatoid | |
| CN105311210A (en) | Pharmaceutical composition for treating rheumatoid bone diseases | |
| CN1686314A (en) | Chinese medicinal preparation for treating cervical vertebra disease | |
| CN104958735A (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
| CN103656463A (en) | Traditional Chinese medicine for treating algomenorrhea | |
| CN102028916B (en) | Thickleaf croton root and clematis root soup for treating lumbocrural pain | |
| CN101507756A (en) | Medicine for treating hemiplegia | |
| CN101934016A (en) | External medicament and mineral-containing plaster for treating arthritis | |
| CN101002864B (en) | Decoction for treating old lumbar soft tissue injury, and its preparing method | |
| CN101028401A (en) | Oral Chinese medicine for treating difficult menstruation | |
| CN101229255A (en) | Chinese traditional medicine formulation for treating acute waist injury | |
| CN101219202A (en) | Soup for strengthening tendon and waist | |
| CN106110217A (en) | A kind of medicated wine for treating cervical spondylosis | |
| CN106214870A (en) | A kind of lavipeditum powder treating rheumatic arthritis and preparation method thereof | |
| CN105106913A (en) | Traditional Chinese medicine composition for treating spleen-kidney yang deficiency type chronic colitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090429 Termination date: 20110929 |